SCHEMBL3923985

SCHEMBL3923985

Cc1c(F)c(F)c(N2CCNCC2)c(F)c1F

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.72
LMNA P02545 1/20 0.72
ADRB1 P08588 6/20 0.41
ADRB2 P07550 2/20 0.38
NCF1 P14598 1/20 0.36
PLD1 Q13393 1/20 0.36
CCR4 P51679 1/20 0.36
HTR2C P28335 2/20 0.35
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
HTR3A P46098 1/20 0.34
HTR3D Q70Z44 1/20 0.34
HTR3C Q8WXA8 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
HRH1 P35367 1/20 0.34
HTR7 P34969 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ACVR1B P36896 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21675441 0.84 ALDH1A1 (0.46) ALDH1A1LMNA
SCHEMBL4754294 0.80 LMNA (0.47) ALDH1A1LMNAADRB1HTR2CHTR3E
SCHEMBL14938158 0.80 LMNA (0.52) ALDH1A1LMNAADRB1HTR2CHTR3E
SCHEMBL5716012 0.76 CA12 (0.46) ALDH1A1LMNA
SCHEMBL28080518 0.75 ALDH1A1 (0.67) ALDH1A1LMNAADRB1ADRB2NCF1
SCHEMBL8452388 0.75 ALDH1A1 (0.50) ALDH1A1LMNAADRB1ADRB2CCR4
SCHEMBL11632304 0.75 ALDH1A1 (0.55) ALDH1A1LMNAADRB1ADRB2HTR2C
SCHEMBL11741883 0.75 ALDH1A1 (0.66) ALDH1A1LMNAADRB1ADRB2NCF1
SCHEMBL24893440 0.74 CA12 (0.55) ALDH1A1LMNA
SCHEMBL14922243 0.74 ALDH1A1 (0.65) ALDH1A1LMNAADRB1ADRB2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192136-A1 BENZOYL-PIPERAZINE DERIVATIVES ALBERATI-GIANI DANIELA 2009-07-30 US disclosed
US-20050070539-A1 Benzoyl-piperazine derivatives F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070539-A1 Benzoyl-piperazine derivatives OPRL1, ACHE, PNMT ALDH1A1 582/4885LMNA 4692/4885ADRB1 97/4885
US-20090192136-A1 BENZOYL-PIPERAZINE DERIVATIVES OPRL1, ACHE, PNMT ALDH1A1 582/4885LMNA 4692/4885ADRB1 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.